IDEAYA Biosciences (IDYA) Receivables (2020 - 2026)
IDEAYA Biosciences (IDYA) reported Receivables of $13.1 million for Q1 2026, up 9.83% sequentially from $11.9 million in Q4 2025.
IDEAYA Biosciences (IDYA) Receivables (2020 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 7 years of Receivables data on file, last reported at $13.1 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $13.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.1 million (changed N/A YoY), and the FY2025 full-year result was $11.9 million, up 398100.0% from the prior year.
- Receivables climbed to $13.1 million in Q1 2026, from $11.9 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $13.1 million in Q1 2026 to a low of $1000.0 in Q2 2024.
- A 5-year average of $2.6 million and a median of $244000.0 in 2022 frame the typical range for Receivables.
- Across the five-year window, Receivables slumped 99.7% in 2024 and surged 398100.0% in 2025, its largest moves.
- Tracing IDYA's Receivables over 5 years: stood at $200000.0 in 2022, then sank by 91.0% to $18000.0 in 2023, then sank by 83.33% to $3000.0 in 2024, then surged by 398100.0% to $11.9 million in 2025, then rose by 9.83% to $13.1 million in 2026.
- Business Quant data shows IDYA's Receivables at $13.1 million in Q1 2026, $11.9 million in Q4 2025, and $3000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | 13.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.12 Mn |
| Dec 31, 2025 | 11.95 Mn |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 6.70 Mn |
| Jun 30, 2023 | 160,000.00 |
| Mar 31, 2023 | 468,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 3.45 Mn |
| Jun 30, 2022 | 288,000.00 |
| Mar 31, 2022 | 697,000.00 |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.33 Mn |
| Mar 31, 2021 | 2.92 Mn |
| Dec 31, 2020 | 1.88 Mn |